Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
16 October 2025 - preview of changes for November 2025
|
Pharmaceutical |
Change |
|---|---|
|
Amphotericin B inj (liposomal) 50 mg vial |
Brand change
|
|
Coal tar (Midwest) soln BP, 200 ml |
price increase |
|
Compound hydroxybenzoate (Midwest) soln, 100 ml |
price increase |
|
Enteral feed 1.5 kcal/ml (Ensure Plus HN) liquid 6.25 g protein, 20 g carbohydrate and 5 g fat per 100 ml, 250 ml can |
to be delisted 1 March 2026 |
|
Ethinyloestradiol with levonorgestrel tab 20 mcg with levonorgestrel 100 mcg and 7 inert tablets |
price increase and addition of PSS |
|
Glycerin with sodium saccharin (Ora-Sweet SF) suspension, 473 ml |
price increase |
|
Glycerin with sucrose (Ora-Sweet) suspension, 473 ml |
price increase |
|
Heparin sodium (Pfizer) inj 5,000 iu per ml, 5 ml ampoule |
new listing and addition of PSS (p’code 2339889) |
|
Heparin sodium (Heparin Sodium Panpharma) inj 5,000 iu per ml, 5 ml vial |
to be delisted 1 May 2026 |
|
Imiquimod (Padagis) crm 5%, 250 mg sachet |
new listing (p’code 2715775) |
|
Lenalidomide (Viatris) (Lenalidomide Viatris) cap 10 mg |
Pharmacode 2673533 to be delisted 1 January 2026 |
|
Lidocaine [lignocaine] hydrochloride oral (gel) soln 2%, 200 ml
|
Brand change
|
|
Methyl hydroxybenzoate (Midwest) powder, 25 g |
price increase |
|
Methylcellulose (Ora-Plus) suspension, 473 ml |
price increase |
|
Methylcellulose (Midwest) Powder, 100 g |
price increase and to be delisted 1 February 2028 |
|
Methylcellulose with glycerin and sodium saccharin (Ora-Blend SF) suspension, 473 ml |
price increase |
|
Methylcellulose with glycerin and sucrose |
price increase |
|
Metoclopramide hydrochloride inj 5 mg per ml, 2 ml ampoule
|
Brand change
|
|
Nortriptyline hydrochloride (Norpress) tab 10 mg and 25 mg |
to be delisted 1 March 2026 |
|
Olanzapine (Zypine) tab 10 mg |
new listing (p’code 2439875) |
|
Omeprazole (Midwest) powder for oral liq, 5 g |
price increase |
|
Oral feed 1.5 kcal/ml (Ensure Plus (Vanilla)) liquid 5.5 g protein, 21.1 g carbohydrate and 4.81 g fat per 100 ml, 237 ml can |
to be delisted 1 July 2026 |
|
Paediatric oral feed 1 kcal/ml (Pediasure (vanilla)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, 250 ml can |
delisted 1 November 2025 |
|
Risperidone (Risperon) oral liq 1 mg per ml, 100 ml |
new listing (p’code 2662396) |
|
Sertraline (Setrona) tab 50 mg and 100 mg |
price increase and addition of PSS |
|
Sodium bicarbonate (Midwest) powder BP, 500 g |
price increase |
|
Syrup (Midwest) liq (pharmaceutical grade), 500 ml |
price increase |
|
Ticagrelor (Ticagrelor Sandoz) tab 90 mg |
amended restriction criteria |